Top Story

Racial, insurance disparities influence chemotherapy receipt for colon cancer

August 3, 2015

Racial disparities in adjuvant chemotherapy receipt have recently reemerged among patients with stage III colon cancer, according to study results.

The researchers attributed these declines in the use of chemotherapy to economic downturn and an increase in Medicaid coverage.


BLOG: Patient financing also can be used as a marketing tool

August 3, 2015
I speak with health care practices on a regular basis. During these conversations, physicians usually ask a range of questions to help determine whether they should…
Timothy S. Fenske, MD In the Journals

Doublet therapy safe, effective in heavily pretreated non-Hodgkin's lymphoma

August 3, 2015
Combination therapy with temsirolimus and bortezomib demonstrated safety and efficacy in patients with heavily pretreated B-cell non-Hodgkin’s lymphoma, according…
Stephen L. Lessnick, MD, PhD Institution Notes

Center for Childhood Cancer and Blood Disorders appoints director

August 2, 2015
Stephen L. Lessnick, MD, PhD, has been named director of the Center for Childhood Cancer and Blood Disorders at Nationwide Children’s Hospital in Columbus…
Josep Tabernero, MD, PhD Association News

ESMO announces 2018 2019 president

August 1, 2015
Josep Tabernero, MD, PhD, will serve as president of the European Society for Medical Oncology in 2018-2019.Tabernero is head of the medical oncology department at Vall…
More News Headlines »
Hematology Oncology Case Consults

The Patient with Chronic Lymphocytic Leukemia

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of patients with chronic lymphocytic leukemia.
More »
Meeting News Coverage Video
VIDEO: 'Care paths' may help manage rising cancer costs

VIDEO: 'Care paths' may help manage rising cancer costs

June 19, 2015
CHICAGO — Brian Bolwell, MD, chairman of Taussig Cancer Institute at Cleveland Clinic, discusses an abstract on…
More »
Tailored Therapies for Myelodysplastic Syndromes

Tailored Therapies for Myelodysplastic Syndromes

This activity is supported by an educational grant from Celgene Corporation.

Myelodysplastic syndromes (MDS) represent a group of myeloid clonal hemopathies with heterogeneous clinical…
More »